Abstract
Background
There is ongoing discussion regarding the mechanisms underlying edema formation in nephrotic syndrome (NS). Many studies published in the last decade reported that primary renal sodium retention was a major factor in edema formation. However, many of the factors influencing edema formation in NS remain unclear, including the role of arginine vasopressin (AVP).
Case-Diagnosis/Treatment
We report a 12-year-old boy with steroid-dependent NS complicated by idiopathic central diabetes insipidus (CDI). He did not develop edema during his first relapse of NS after developing CDI, despite having hypoalbuminemia. He had polydipsia, polyuria, low urine osmolality, and a low serum arginine AVP level. His fractional excretion of sodium was only slightly low. Endocrinological testing and magnetic resonance imaging revealed idiopathic CDI. After starting desmopressin therapy, he developed edema when his NS relapsed.
Conclusions
This is the first known reported case of NS in a patient with CDI. The findings suggest that appropriate AVP secretion in response to an increase in serum osmolality caused by renal sodium retention is necessary for excess extracellular fluid accumulation in NS. Further investigation is needed to more fully understand the role of AVP in edema formation in NS.
This is a preview of subscription content, log in via an institution to check access.
References
Siddall EC, Radhakrishnan J (2012) The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 82:635–642
Lourdel S, Loffing J, Favre G, Paulais M, Nissant A, Fakitsas P, Créminon C, Féraille E, Verrey F, Teulon J, Doucet A, Deschênes G (2005) Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. J Am Soc Nephrol 16:3642–3650
Kim SW, Wang W, Neisen J, Praetorius J, Kwon TH, Knepper MA, Frøkiaer J, Nielsen S (2004) Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 286:F922–F935
Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M (2012) Diabetes insipidus—diagnosis and management. Horm Res Paediatr 77:69–84
Rascher W, Tulassay T (1987) Hormonal regulation of water metabolism in children with nephrotic syndrome. Kidney Int Suppl 21:S83–S89
Richards GE, Thomsett MJ, Bostin BA, Dimeglio LA, Shulman DI, Draznin M (2011) Natural history of idiopathic diabetes insipidus. J Pediatr 159:566–570
Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O (2009) Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 20:299–310
Andersen RF, Buhl KB, Jensen BL, Svenningsen P, Rittig S (2013) Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC. Pediatr Nephrol 28:1227–1234
Deschênes G, Doucet A (2000) Collecting duct Na+/K+-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol 11:604–615
Besse-Eshmann V, Klisic J, Nief V, Le Hir M, Kaissling B, Ambühl PM (2002) Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome. J Am Soc Nephrol 13:2199–2206
Ryo HJ, Summer SN, Niederberger M, Kim JK, Schrier RW (1995) Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 25:58–62
Balanescu S, Kopp P, Gaskill NG, Schindler C, Rutishauser J (2011) Correlation of plasma Copeptin and vasopressin concentration in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab 96:1046–1052
Snyder PM (2002) The epithelial Na + channel: cell surface insertion and retrieval in Na + homeostasis and hypertension. Endocr Rev 23:258–275
Mironova E, Bugaj V, Roos KP, Kohan DE, Stockand D (2012) Aldosterone-independent regulation of the epithelial Na + channel (ENac) by vasopressin in adrenalectomized mice. Proc Natl Acad Sci U S A 109:10095–10100
Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T (2009) Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Clin Exp Nephrol 13:438–446
Acknowledgements
We are grateful to Dr. Kaede Yanagita for her useful comments on this manuscript.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Konomoto, T., Tanaka, E., Imamura, H. et al. Nephrotic syndrome complicated by idiopathic central diabetes insipidus. Pediatr Nephrol 29, 927–930 (2014). https://doi.org/10.1007/s00467-013-2728-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-013-2728-9